Upgrade to SI Premium - Free Trial

Doximity Announces Fiscal 2025 First Quarter Financial Results

August 8, 2024 4:01 PM

Total revenues of $126.7 million, up 17% year-over-year

Net income growth of 46% and adjusted EBITDA growth of 42% year-over-year

SAN FRANCISCO--(BUSINESS WIRE)-- Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2025 first quarter ended June 30, 2024.

“We were pleased to deliver strong profits and record engagement last quarter, as we beat on both our top and bottom lines,” said Jeff Tangney, co-founder and CEO of Doximity. “Last quarter, a record 590,000 unique providers used our AI, telehealth, messaging, and scheduling workflow tools to save time and better serve their patients.”

Fiscal 2025 First Quarter Financial Highlights

All comparisons, unless otherwise noted, are to the three months ended June 30, 2023.

Financial Outlook

Doximity is providing guidance for its fiscal second quarter ending September 30, 2024 as follows:

Doximity is providing guidance for its fiscal year ending March 31, 2025 as follows:

Conference Call Information

Doximity posted prepared remarks on its investor relations website at https://investors.doximity.com. Doximity will host a webcast today at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to discuss these financial results. To listen to a live audio webcast, please visit the Company’s Investor Relations page at https://investors.doximity.com. The archived webcast will be available on the Company’s Investor Relations page shortly after the call.

About Doximity

Founded in 2010, Doximity is the leading digital platform for U.S. medical professionals. The company's network members include more than 80% of U.S. physicians across all specialties and practice areas. Doximity provides its verified clinical membership with digital tools built for medicine, enabling them to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. Doximity's mission is to help doctors be more productive so they can provide better care for their patients.

Forward-Looking Statements

Statements we make in this press release may include statements which are not historical facts and are considered forward-looking within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act, which are usually identified by the use of words such as “anticipates,” “believes,” “estimates,” “expects,” “intends,” “may,” “plans,” “projects,” “seeks,” “should,” “will,” and variations of such words or similar expressions. We intend these forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act and Section 21E of the Securities Exchange Act and are making this statement for purposes of complying with those safe harbor provisions. These forward-looking statements reflect our current views about our plans, intentions, expectations, strategies and prospects, which are based on the information currently available to us and on assumptions we have made. Although we believe that our plans, intentions, expectations, strategies and prospects as reflected in or suggested by those forward-looking statements are reasonable, we can give no assurance that the plans, intentions, expectations, or strategies will be attained or achieved. Furthermore, actual results may differ materially from those described in the forward-looking statements and will be affected by a variety of risks and factors including (i) the timing and scope of anticipated stock repurchases; (ii) the impact of uncertainty in the current economic environment and macroeconomic uncertainty; (iii) our ability to retain existing members or add new members to our platform and maintain or grow their engagement with our platform; (iv) our ability to attract new customers or retain existing customers; (v) the impact of our prioritization of our members’ interests; (vi) breaches in our security measures or unauthorized access to members’ data; (vii) our ability to maintain or manage our growth, and other risks and factors that are beyond our control including, without limitation, those set forth in the section entitled “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended March 31, 2024 and as may be updated in any subsequent Quarterly Reports on Form 10-Q. Moreover, we operate in a very competitive and rapidly changing environment. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all risks and uncertainties that could cause actual results to differ materially from those contained in our forward-looking statements. The forward-looking statements made in this press release relate only to management’s beliefs and assumptions as of this date. We assume no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

DOXIMITY, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands)

(unaudited)

June 30, 2024

March 31, 2024

Assets

Current assets:

Cash and cash equivalents

$

111,442

$

96,785

Marketable securities

639,046

666,115

Accounts receivable, net

120,910

101,332

Prepaid expenses and other current assets

37,068

48,709

Total current assets

908,466

912,941

Property and equipment, net

12,869

12,318

Deferred income tax assets

44,742

45,068

Operating lease right-of-use assets

11,852

12,332

Intangible assets, net

26,256

27,317

Goodwill

67,940

67,940

Other assets

1,333

1,458

Total assets

$

1,073,458

$

1,079,374

Liabilities and Stockholders’ Equity

Current liabilities:

Accounts payable

$

1,656

$

2,253

Accrued expenses and other current liabilities

28,488

43,703

Deferred revenue, current

102,943

99,145

Operating lease liabilities, current

2,190

2,149

Total current liabilities

135,277

147,250

Deferred revenue, non-current

116

211

Operating lease liabilities, non-current

11,841

12,397

Contingent earn-out consideration liability, non-current

5,349

10,895

Other liabilities, non-current

7,295

7,224

Total liabilities

159,878

177,977

Stockholders' Equity

Preferred stock

Common stock

186

187

Additional paid-in capital

841,470

823,885

Accumulated other comprehensive loss

(1,008

)

(2,664

)

Retained earnings

72,932

79,989

Total stockholders’ equity

913,580

901,397

Total liabilities and stockholders’ equity

$

1,073,458

$

1,079,374

DOXIMITY, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share data)

(unaudited)

Three Months Ended June 30,

2024

2023

Revenue

$

126,676

$

108,469

Cost of revenue(1)

13,550

13,153

Gross profit

113,126

95,316

Operating expenses(1):

Research and development

22,574

21,931

Sales and marketing

35,244

34,455

General and administrative

9,255

9,247

Total operating expenses

67,073

65,633

Income from operations

46,053

29,683

Other income, net

7,116

4,839

Income before income taxes

53,169

34,522

Provision for income taxes

11,792

6,116

Net income

$

41,377

$

28,406

Net income per share attributable to Class A and Class B common stockholders:

Basic

$

0.22

$

0.15

Diluted

$

0.21

$

0.13

Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders:

Basic

185,610

194,521

Diluted

199,224

212,355

(1) Costs and expenses include stock-based compensation expense as follows (in thousands):

Three Months Ended June 30,

2024

2023

Cost of revenue

$

2,894

$

2,461

Research and development

4,684

3,256

Sales and marketing

6,586

5,995

General and administrative

2,926

2,289

Total stock-based compensation expense

$

17,090

$

14,001

DOXIMITY, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)

(unaudited)

Three Months Ended June 30,

2024

2023

Cash flows from operating activities

Net income

$

41,377

$

28,406

Adjustments to reconcile net income to net cash provided by operating activities:

Depreciation and amortization

2,562

2,604

Stock-based compensation, net of amounts capitalized

17,090

14,001

Non-cash lease expense

481

537

Accretion of discount on marketable securities, net

(2,360

)

(299

)

Net loss on sale of marketable securities

273

Amortization of deferred contract costs

2,726

2,667

Change in fair value of contingent earn-out consideration liability

202

269

Other

(738

)

(421

)

Changes in operating assets and liabilities:

Accounts receivable

(19,372

)

14,032

Prepaid expenses and other assets

10,460

2,589

Deferred contract costs

(1,431

)

(1,210

)

Accounts payable, accrued expenses and other liabilities

(12,942

)

677

Deferred revenue

3,704

(6,922

)

Operating lease liabilities

(516

)

(3

)

Net cash provided by operating activities

41,243

57,200

Cash flows from investing activities

Purchases of property and equipment

(70

)

Internal-use software development costs

(1,704

)

(1,494

)

Purchases of marketable securities

(170,413

)

(35,284

)

Maturities of marketable securities

202,058

116,649

Sales of marketable securities

37,525

Net cash provided by investing activities

29,941

117,326

Cash flows from financing activities

Proceeds from issuance of common stock upon exercise of stock options

2,551

3,285

Taxes paid related to net share settlement of equity awards

(2,394

)

(1,964

)

Repurchase of common stock

(51,214

)

(21,755

)

Payment of contingent consideration related to a business combination

(5,470

)

(5,390

)

Net cash used in financing activities

(56,527

)

(25,824

)

Net increase in cash and cash equivalents

14,657

148,702

Cash and cash equivalents, beginning of period

96,785

158,027

Cash and cash equivalents, end of period

$

111,442

$

306,729

Supplemental disclosures of cash flow information

Cash paid for taxes, net of refunds

$

12,907

$

Non-GAAP Financial Measures

To supplement our condensed consolidated financial statements, which are prepared and presented in accordance with accounting principles generally accepted in the United States (“GAAP”), the Company uses the following non-GAAP measures of financial performance:

We use these non-GAAP financial measures internally for financial and operational decision-making purposes and as a means to evaluate period-to-period comparisons. Non-GAAP financial measures are not meant to be considered in isolation or as a substitute for comparable GAAP financial measures and should be read only in conjunction with our condensed consolidated financial statements prepared in accordance with GAAP. Our presentation of non-GAAP financial measures may not be comparable to similar measures used by other companies. We encourage investors to carefully consider our results under GAAP, as well as our supplemental non-GAAP information and the reconciliation between these presentations, to more fully understand our business. Please see the tables included at the end of this release for the reconciliation of GAAP to non-GAAP results.

Key Business Metrics

Reconciliation of GAAP to Non-GAAP Financial Measures

The following tables reconcile the specific items excluded from GAAP metrics in the calculation of non-GAAP metrics for the periods shown below:

Three Months Ended June 30,

2024

2023

(unaudited)

(in thousands, except percentages)

Net income

$

41,377

$

28,406

Adjusted to exclude the following:

Stock-based compensation

17,090

14,001

Depreciation and amortization

2,562

2,604

Provision for income taxes

11,792

6,116

Change in fair value of contingent earn-out consideration liability

202

269

Other income, net

(7,116

)

(4,839

)

Adjusted EBITDA

$

65,907

$

46,557

Revenue

$

126,676

$

108,469

Net income margin

32.7

%

26.2

%

Adjusted EBITDA margin

52.0

%

42.9

%

Three Months Ended June 30,

2024

2023

(unaudited)

(in thousands)

Net cash provided by operating activities

$

41,243

$

57,200

Purchases of property and equipment

(70

)

Internal-use software development costs

(1,704

)

(1,494

)

Free cash flow

$

39,539

$

55,636

Other cash flow components:

Net cash provided by investing activities

$

29,941

$

117,326

Net cash used in financing activities

$

(56,527

)

$

(25,824

)

Three Months Ended June 30,

2024

2023

(unaudited)

(in thousands, except per share data and percentages)

GAAP cost of revenue

$

13,550

$

13,153

Adjusted to exclude the following:

Stock-based compensation

(2,894

)

(2,461

)

Amortization of acquired intangibles

(137

)

Non-GAAP cost of revenue

$

10,656

$

10,555

GAAP gross profit

$

113,126

$

95,316

Adjusted to exclude the following:

Stock-based compensation

2,894

2,461

Amortization of acquired intangibles

137

Non-GAAP gross profit

$

116,020

$

97,914

GAAP gross margin

89.3

%

87.9

%

Non-GAAP gross margin

91.6

%

90.3

%

GAAP research and development expense

$

22,574

$

21,931

Adjusted to exclude the following:

Stock-based compensation

(4,684

)

(3,256

)

Non-GAAP research and development expense

$

17,890

$

18,675

GAAP sales and marketing expense

$

35,244

$

34,455

Adjusted to exclude the following:

Stock-based compensation

(6,586

)

(5,995

)

Amortization of acquired intangibles

(1,061

)

(1,061

)

Change in fair value of contingent earn-out consideration liability

(202

)

(269

)

Non-GAAP sales and marketing expense

$

27,395

$

27,130

GAAP general and administrative expense

$

9,255

$

9,247

Adjusted to exclude the following:

Stock-based compensation

(2,926

)

(2,289

)

Non-GAAP general and administrative expense

$

6,329

$

6,958

GAAP operating expense

$

67,073

$

65,633

Adjusted to exclude the following:

Stock-based compensation

(14,196

)

(11,540

)

Amortization of acquired intangibles

(1,061

)

(1,061

)

Change in fair value of contingent earn-out consideration liability

(202

)

(269

)

Non-GAAP operating expense

$

51,614

$

52,763

GAAP operating income

$

46,053

$

29,683

Adjusted to exclude the following:

Stock-based compensation

17,090

14,001

Amortization of acquired intangibles

1,061

1,198

Change in fair value of contingent earn-out consideration liability

202

269

Non-GAAP operating income

$

64,406

$

45,151

GAAP net income

$

41,377

$

28,406

Adjusted to exclude the following:

Stock-based compensation

17,090

14,001

Amortization of acquired intangibles

1,061

1,198

Change in fair value of contingent earn-out consideration liability

202

269

Income tax effect of non-GAAP adjustments (1)

(3,854

)

(3,248

)

Non-GAAP net income

$

55,876

$

40,626

Non-GAAP net income margin

44.1

%

37.5

%

Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders:

Basic

185,610

194,521

Diluted

199,224

212,355

Non-GAAP net income per share attributable to Class A and Class B stockholders:

Basic

$

0.30

$

0.21

Diluted

$

0.28

$

0.19

(1)

For the three months ended June 30, 2024 and 2023, management used an estimated annual effective non-GAAP tax rate of 21.0%.

Investor Relations Contact:

Perry Gold

[email protected]

Media Contact:

Amanda Cox

[email protected]

Source: Doximity

Categories

Business Wire Press Releases

Next Articles